Topics:

Cardiovascular Diseases

Cholesterol Management 2013 and Beyond: Two Roads Diverged

The week of November 11, 2013, saw release of the long-awaited update to what had become a stale approach to cholesterol management in the long-term war against cardiovascular disease. Is the document a radical departure from what had gone before? The answer is a resounding “yes.”

Cardiovascular Diseases

Based on 2013 clinical guidelines, nearly three-quarters of HIV-infected patients with dangerous subclinical atherosclerotic plaque would not be considered for statin therapy, a new study finds.

HIV-infected patients have a 2-fold increased risk for MI vs HIV-negative patients. While many are treated for common risk factors, many of those do not reach clinical targets.

Lone atrial fibrillation describes isolated episodes of AF that have been previously considered benign. A revised picture is emerging, according to a new study.

A very large observational study heightens concern around use of digoxin in the treatment of newly diagnosed atrial fibrillation, despite guideline recommendations.

A new study identifies obesity and inactivity as independent risk factors for atrial fibrillation in postmenopausal women. Exercise attenuated the risk in the study cohort.

Not all patients who meet indications for statin therapy are at equal risk for the development of diabetes. What would you tell this 58-year-old man who just learned he's a candidate for a high-potency formulation?

Pages

Subscribe to Cardiovascular Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.